ReviewAmerican journal of cancer research2017

Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Fengzhi Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.